ARTHQ (Arch Therapeutics) Accounts Payable: $2.92 Mil (As of Jun. 2024)


ARTHQ Arch Therapeutics Inc ARTHQ
12 GF Score
Price $0.00
View Full Analysis

What is Arch Therapeutics Accounts Payable?

Arch Therapeutics ARTHQ -99.00% 12 Accounts Payable is $2.92 Mil as of Jun. 2024. GuruFocus rates ARTHQ with a GF Score™ of 12/100.

Arch Therapeutics's Accounts Payable for the quarter that ended in Jun. 2024 was $2.92 Mil.

Arch Therapeutics's quarterly Accounts Payable increased from Dec. 2023 ($2.77 Mil) to Mar. 2024 ($2.97 Mil) but then declined from Mar. 2024 ($2.97 Mil) to Jun. 2024 ($2.92 Mil).

Arch Therapeutics's annual Accounts Payable increased from Sep. 2021 ($0.41 Mil) to Sep. 2022 ($1.33 Mil) and increased from Sep. 2022 ($1.33 Mil) to Sep. 2023 ($2.30 Mil).

Arch Therapeutics Accounts Payable Related Terms

Arch Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Arch Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Therapeutics Accounts Payable Chart

Arch Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.34 0.41 1.33 2.30

Arch Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.47 2.30 2.77 2.97 2.92
ARTHQ
12GF Score
Arch Therapeutics Inc ARTHQ
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $2.92 Mil mean?
Arch Therapeutics (ARTHQ) has a Accounts Payable of $2.92 Mil as of Jun. 2024. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Arch Therapeutics and its competitors.
Is Arch Therapeutics' Accounts Payable too high?
Arch Therapeutics' current Accounts Payable is $2.92 Mil. Overall, Arch Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Arch Therapeutics' Accounts Payable compare to GRTSQ and MTEM?
Arch Therapeutics' Accounts Payable of $2.92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Arch Therapeutics and its competitors. Arch Therapeutics's current Accounts Payable is $2.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Therapeutics stock overvalued right now?
Arch Therapeutics (ARTHQ) has a current Accounts Payable of $2.92 Mil. The current Accounts Payable is $2.92 Mil. Arch Therapeutics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Arch Therapeutics (ARTHQ), the current Accounts Payable is $2.92 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Therapeutics Business Description

Address 235 Walnut Street, Suite 6, Framingham, MA, USA, 01702
Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.
12GF Score

Get the complete analysis for ARTHQ

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price